The Washington Post, January 5, 2011. Joshua M. Sharfstein, the second-in-command at the Food and Drug Administration, is leaving that post after less than two years to become Maryland’s top public health official, Gov. Martin O’Malley said Tuesday.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Panel Votes to Expand Surgery for Less Obese
New York Times, December 3, 2010. A federal advisory panel Friday endorsed an expansion of the use of Allergan’s Lap-Band stomach-restricting device to patients who are less than severely obese. Where’s the long-term data?
Read More »Experts Endorse Obesity Surgery
The Washington Post, December 3, 2010. However, this worries NCHR President: “We do patients no favors when we sell them implanted medical products that have been tested on just a few patients for only one year.”
Read More »F.D.A. Rejects Qnexa, a Third Weight-Loss Drug
New York Times, October 29, 2010. FDA requested the company provide thorough evaluation of the drug’s potential for causing birth defects and heart problems.
Read More »Glaxo’s Avandia to Be Pulled From EU Market, Restricted in U.S.
Bloomberg, September 23, 2010. GlaxoSmithKline Plc‘s Avandia, once the world’s best-selling diabetes drug, will be withdrawn in Europe and restricted in the U.S. after a three-year review of the medicine’s heart risks.
Read More »